BioNTech Phase 3 trial of variant-adapted BNT162b2 COVID vaccine recruitingSep 30Weekly roundup, 7 itemsatirmociclibberobenatide
Peking University registers finerenone-semaglutide trial for obesity kidney diseaseSep 30Trial updateBayerfinerenone
Novo Nordisk adds four registrations: new molecule trial, CagriSema switch study, real-world dataSep 30Weekly roundup, 7 itemsCagrisemaNNC0705-0002Updated
Alveus registers Phase 2 trial of ALV-100 for weight-loss maintenance after semaglutideSep 24Trial updateAlveus Therapeutics, Incsemaglutide
Lilly's orforglipron posts Phase 3 diabetes results; six new trials registeredSep 18Weekly roundup, 7 itemsEli Lillyorforglipron
Novo Nordisk registers Phase 3 obesity trial in Japan; new CagriSema switch studySep 16Weekly roundup, 2 itemsCagrisemaNNC0487-0111
iBio reports fiscal 2026 results, cites progress across obesity antibody pipelineAug 28Quarterly updateiBio, Inc.
Novo Nordisk posts PIONEER TEENS results; registers three new trials for obesity and injectionsAug 21Weekly roundup, 4 itemsNNC0721-8060Novo Nordisk A/S
Novo Nordisk posts results for two semaglutide trials, opens new NNC0487-0111 studyAug 14Weekly roundup, 3 itemsNNC0487-0111Novo Nordisk A/S
Veru's Phase 2b PLATEAU trial fully enrolled with 239 obesity patientsAug 10Quarterly updateenobosarmVeru Inc.
Novo Nordisk registers Phase 3 cagrilintide trial; Penn semaglutide study posts resultsAug 4Weekly roundup, 2 itemscagrilintideNovo Nordisk A/S
Novo Nordisk registers Korean MASLD/MASH real-world study and semaglutide back pain trialJul 31Weekly roundup, 2 itemsNovo Nordisk A/Ssemaglutide
Neumora reports favorable NMRA-215 toxicology data, still targets Q4 2026 INDJul 27Clinical readoutNeumora Therapeutics, Inc.
Dr. Reddy's records Rs.2,397 million provision for out-of-spec semaglutideJul 22Quarterly updateDr Reddys Laboratories Ltdsemaglutide
Sign inSign in